The future success of translational research relies upon training a cadre of dedicated and talented individuals who are well versed in human biology. There is a critical need for graduate programs that provide for the integrated training of PhD students in the translation of advances in basic investigation to the prevention, diagnosis, and treatment of disease. Harvard University created the Leder Human Biology and Translational Medicine (LHB) Program to fulfill this goal. An outline of the Program is given below.
Goals of LHB Program
The LHB Program has two goals. First, it provides PhD students with a working knowledge of the fundamentals of human biology and disease, primarily through a series of courses, to enrich their basic science training and broaden their research interests. Second, it demystifies the culture and practice of medicine, facilitating future collaborations with clinicians and physician-scientists, through activities designed to bring students into a hospital environment for direct contact with physicians, patients, medical students, and physician-scientists. The full program runs for one and one half years, beginning in Spring of the G1 Year, and it is interdigitated with a student's other graduate program requirements. Students who successfully complete the LHB Program will receive a certificate in Human Biology and Tranlational Medicine with their PhDs. Students who do not enter the LHB program but wish to learn about human biology will have access to LHB courses on an ad hoc basis. After the formal LHB Program is completed, students are encouraged to continue to participate in Program activities and are provided with ongoing mentoring opportunities throughout their time at Harvard.
To the HILS G1 PhD Student Community,
Information Session--Leder Human Biology and Translational Medicine Program
There will be an information session on October 3 for all G1 students interested in the Leder Human Biology and Translational Medicine Program. It will run 12-1, with lunch, at the Longwood Medical Area campus in the New Research Building (NRB, 77 Avenue Louis Pasteur, Room 254). An outline of the program will be presented, and current students and faculty will be present to answer questions and provide discussion. The program is open to all HILS G1 students.
The application is due November 13, and the application form and instructions can be downloaded from http://dms.hms.harvard.edu/lhb/Applications.html. Interviews will be held November 15-22, admissions decisions will be made in late November, with a Welcome Dinner the first week in December. The first class is the Case Studies in Translational Medicine Class, beginning the first week in January. Note that this is a required class.
Questions? Concerns? Contact Connie Cepko or Thomas Michel for more information. Our contact information is below.
Department of Genetics and Howard Hughes Medical Institute
Co-Director, Leder Human Biology and Translational Medicine
Harvard Medical School
77 Avenue Louis Pasteur
NRB Room 360
Boston, Ma. 02115
Assistant: Kim Burman
Thomas Michel, MD, PhD
Professor of Medicine and Biochemistry, Harvard Medical School
Senior Physician in Cardiovascular Medicine, Brigham and Women‚s Hospital
Co-Director, Leder Human Biology and Translational Medicine Program
Thorn Building 1210A, 75 Francis Street
Boston, MA 02115
Phone 617-732-7376 FAX 617-732-5132
Copyright © 2012 by The President and Fellows of Harvard College